Literature DB >> 1655307

Acetyl-L-carnitine enhances the response of PC12 cells to nerve growth factor.

G Taglialatela1, L Angelucci, M T Ramacci, K Werrbach-Perez, G R Jackson, J R Perez-Polo.   

Abstract

We have demonstrated that treatment of rat pheochromocytoma (PC12) cells with acetyl-L-carnitine (ALCAR) stimulates the synthesis of nerve growth factor receptors (NGFR). ALCAR has also been reported to prevent some age-related impairments of the central nervous system (CNS). In particular, ALCAR reduces the loss of NGFR in the hippocampus and basal forebrain of aged rodents. On these bases, a study on the effect of NGF on the PC12 cells was carried out to ascertain whether ALCAR induction of NGFR resulted in an enhancement of NGF action. Treatment of PC12 cells for 6 days with ALCAR (10 mM) stimulated [125I]NGF PC12 cell uptake, consistent with increased NGFR levels. Also, neurite outgrowth elicited in PC12 cells by NGF (100 ng/ml) was greatly augmented by ALCAR pretreatment. When PC12 cells were treated with 10 mM ALCAR and then exposed to NGF (1 ng/ml), an NGF concentration that is insufficient to elicit neurite outgrowth under these conditions, there was an ALCAR effect on neurite outgrowth. The concentration of NGF necessary for survival of serum-deprived PC12 cells was 100-fold lower for ALCAR-treated cells as compared to controls. The minimal effective dose of ALCAR here was between 0.1 and 0.5 mM. This is similar to the reported minimal concentration of ALCAR that stimulates the synthesis of NGFR in these cells. The data here presented indicate that one mechanism by which ALCAR rescues aged neurons may be by increasing their responsiveness to neuronotrophic factors in the CNS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655307     DOI: 10.1016/0165-3806(91)90102-o

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  10 in total

Review 1.  Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Authors:  Mike Youle
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

Authors:  A A Sima; H Ristic; A Merry; M Kamijo; S A Lattimer; M J Stevens; D A Greene
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

3.  Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression.

Authors:  Lorenzo Di Cesare Mannelli; Elisa Vivoli; Alberto Salvicchi; Nicola Schiavone; Aleardo Koverech; Masa Messano; Raffaella Nicolai; Paola Benatti; Alessandro Bartolini; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2011-05-18       Impact factor: 4.530

4.  Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.

Authors:  David B Engle; Jennifer A Belisle; Jennifer A A Gubbels; Sarah E Petrie; Paul R Hutson; David M Kushner; Manish S Patankar
Journal:  Gynecol Oncol       Date:  2009-03       Impact factor: 5.482

5.  Neurite outgrowth in PC12 cells stimulated by acetyl-L-carnitine arginine amide.

Authors:  G Taglialatela; D Navarra; A Olivi; M T Ramacci; K Werrbach-Perez; J R Perez-Polo; L Angelucci
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

6.  Ganglioside GM1 binds to the Trk protein and regulates receptor function.

Authors:  T Mutoh; A Tokuda; T Miyadai; M Hamaguchi; N Fujiki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats.

Authors:  Amar Karalija; Liudmila N Novikova; Paul J Kingham; Mikael Wiberg; Lev N Novikov
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

8.  New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Janet Schloss; Maree Colosimo; Luis Vitetta
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Jan-Mar

9.  Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial.

Authors:  Matthew W T Curran; Jaret Olson; Michael Morhart; Dory Sample; K Ming Chan
Journal:  Trials       Date:  2016-04-14       Impact factor: 2.279

10.  Treatment with acetyl-L-carnitine exerts a neuroprotective effect in the sciatic nerve following loose ligation: a functional and microanatomical study.

Authors:  Daniele Tomassoni; Lorenzo Di Cesare Mannelli; Vincenzo Bramanti; Carla Ghelardini; Francesco Amenta; Alessandra Pacini
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.